Biohit Oyj is a Finnish company which develops, manufactures, and markets biotech and diagnostics products for use in research and health care.
Summary
Biohit was established in 1988 in Finland by Professor Osmo Suovaniemi (M.D., Ph.D.), previously known as the founder of Labsystems (Finnish company).[1][2] He stepped down from the CEO position in June 2011, but remains actively involved with the company through positions on several advisory boards. Biohit is a globally operating Finnish biotechnology company. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) has been quoted on NASDAQ OMX Helsinki since 1999, Small cap/Healthcare. Semi Korpela was appointed CEO in 2011.
Markets
Biohit's two businesses are acetaldehyde-eliminating products and diagnostics. More than 90% of Biohit's sales occur outside Finland.[3]